Search clinical trials for: RTA 901 capsules
Total 2165 results
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Brazil, Canada, France, Germany, Hungary, India, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom
-
UCB PharmaCompletedRheumatoid ArthritisUnited States, Bulgaria, Croatia, Czechia, Estonia, Israel, Latvia, Lithuania, Poland, Russian Federation, Serbia, Slovakia, Ukraine
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Brazil, Canada, France, Germany, Hungary, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom, Australia, Belgium, Bulgaria, Czechia, Estonia, Israel, Korea, Republic of, T... and more
-
Millennium Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Myelofibrosis | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Waldenstrom's Macroglobulinemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Non-Hodgkins Lymphoma | Myeloid Metaplasia | Philadelphia Chromosome-negative CML | Advanced PolycythemiaUnited States
-
ADC Therapeutics S.A.Active, not recruitingAdvanced Solid TumorsUnited States, Spain, United Kingdom
-
Stemline Therapeutics, Inc.CompletedStudy of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors With Advanced Solid TumorsAdvanced Solid TumorUnited Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedLymphoma | Advanced Solid TumorsUnited States
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Spain, Canada, Portugal, Poland, Belgium, Hungary, Lithuania
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Poland
-
Urovant Sciences GmbHCompletedIrritable Bowel SyndromeUnited States
-
Reata, a wholly owned subsidiary of BiogenRecruitingA Phase 2 Study of RTA 901 in Patients With Diabetic Peripheral Neuropathic Pain (CYPRESS) (CYPRESS)Diabetic Peripheral Neuropathic PainUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyocardial Infarction | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Ischemic Attack, Transient | Angina Pectoris | Cerebrovascular Accident
-
Atrium Medical CorporationCompletedAcute Anterior Myocardial InfarctionUnited States, Germany, United Kingdom, Austria, Netherlands, Poland
-
The Immune Response CorporationCompleted
-
Aerami TherapeuticsCompletedPulmonary Arterial HypertensionAustralia
-
Mesoblast, Inc.Juvenile Diabetes Research FoundationCompletedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent | Juvenile DiabetesUnited States
-
Andromeda Biotech Ltd.CompletedType 1 DiabetesFrance, Italy, United Kingdom, Israel, South Africa, Spain, Austria, Czech Republic, Finland, Germany, Greece
-
Dartmouth-Hitchcock Medical CenterAerasCompleted
-
Eyegate Pharmaceuticals, Inc.CompletedPain, Postoperative | Cataract | Anterior Chamber InflammationUnited States
-
Dartmouth-Hitchcock Medical CenterMuhimbili University of Health and Allied SciencesCompleted
-
Hadassah Medical OrganizationDIABETES UNITUnknownGiving a Vaccination in Three Months
-
Shahid Beheshti UniversityTehran University of Medical Sciences; Negah Eye CenterActive, not recruitingKeratoconus | Corneal Cross-LinkingIran, Islamic Republic of
-
Shahid Beheshti University of Medical SciencesCompletedHypoxic Ischaemic Encephalopathy Due to Cardiac ArrestIran, Islamic Republic of
-
Dartmouth-Hitchcock Medical CenterNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV Infections | TuberculosisTanzania
-
BioMarin PharmaceuticalCompletedPhenylketonuria (PKU)United States, Turkey, Canada, France, Germany, Italy, United Kingdom
-
National University Hospital, SingaporeCompletedCognitive ImpairmentSingapore, Philippines, Vietnam
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Latvia, Hungary, Canada, Lithuania, Poland
-
SanofiCompleted
-
Akdeniz UniversityCompletedPeriodontitis | Gingival Crevicular Fluid | Interleukin 1-beta | Bactericidal Permeability ProteinTurkey
-
Trefoil Therapeutics, Inc.CompletedCorneal Endothelial DystrophyUnited States
-
Encore Medical, L.P.DJO IncorporatedCompletedShoulder Arthropathy | Rotator Cuff Deficiency | Failed Shoulder ReplacementUnited States
-
Bristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
Instituto Grifols, S.A.CompletedHemostasisUnited States
-
Bausch Health Americas, Inc.Completed
-
Chinese Academy of Medical Sciences, Fuwai HospitalUnknownCoronary Artery Disease | Percutaneous Coronary InterventionChina
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Allievex CorporationCompletedMucopolysaccharidosis Type IIIB | Mucopolysaccharidosis Type 3 B | MPS III B | MPS 3 BUnited States, Spain, Turkey, Taiwan, Australia, Colombia, Germany, United Kingdom
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe Patients Untreated or Treated With rhGAASpain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania
-
AlexionTerminated
-
Astellas Pharma Global Development, Inc.Seagen Inc.Approved for marketingLocally Advanced or Metastatic Urothelial Carcinoma (UC)United States
-
EdiGene Inc.The First Affiliated Hospital of Henan University of Science and Technology; Changping LaboratoryRecruitingLupus Erythematosus, SystemicChina
-
Urovant Sciences GmbHActive, not recruitingOveractive BladderUnited States
-
Entrada Therapeutics, Inc.SuspendedMitochondrial Neurogastrointestinal EncephalomyopathyUnited States, Turkey
-
Eisai Inc.Terminated
-
Avenue Therapeutics, Inc.CompletedPain ManagementUnited States
-
HeartFlow, Inc.Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Baim Institute for Clinical Research and other collaboratorsCompletedCoronary Artery DiseaseUnited States
-
Vertex Pharmaceuticals IncorporatedApproved for marketing